Fisher Asset Management’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.7K Hold
43,400
– – ﹤0.01% 1059
2026
Q2
$11.8K Hold
43,400
– – ﹤0.01% 1035
2026
Q1
$11.4K Hold
43,400
– – ﹤0.01% 1013
2025
Q4
$12.2K Hold
43,400
– – ﹤0.01% 1014
2025
Q3
$18.1K Buy
+43,400
New +$16.5K ﹤0.01% 1011

Other funds holding IGC

Fisher Asset Management's IGC Position: Q3 2026 in Review

Fisher Asset Management held its IGC Pharma (IGC) position steady in Q3 2026 at 43,400 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

Fisher Asset Management first reported a position in IGC in Q3 2025 and has held it in 5 quarters since. The position peaked at $18.1K in Q3 2025. 29 funds tracked by Wall St. Rank hold IGC as of Q3 2026.

  • Fisher Asset Management held 43,400 shares of IGC Pharma worth $11.7K as of Q3 2026.
  • Fisher Asset Management left its IGC Pharma share count unchanged in Q3 2026.
  • IGC Pharma made up ﹤0.01% of Fisher Asset Management's portfolio in Q3 2026, its #1059 holding.
  • Fisher Asset Management first reported a position in IGC Pharma in Q3 2025 and has held it in 5 quarters since.
  • Fisher Asset Management's IGC Pharma position peaked at $18.1K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.

Based on Fisher Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.